FULGENT GENETICS, INC. Operating Lease, Expense
FULGENT GENETICS, INC. (FLGT) reported Operating Lease, Expense of $133.00 thousand for the 3-month period ending 2019-06-30, per its 10-Q filed 2019-08-12.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2019-08-12
- FULGENT GENETICS, INC. operating lease, expense for the quarter ending 2019-06-30 was $133.00K, a 11.76% increase year-over-year.
- FULGENT GENETICS, INC. operating lease, expense for the quarter ending 2019-03-31 was $133.00K, a 22.02% increase year-over-year.
- FULGENT GENETICS, INC. operating lease, expense for the quarter ending 2018-06-30 was $119.00K.
- FULGENT GENETICS, INC. operating lease, expense for the quarter ending 2018-03-31 was $109.00K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 6 month |
|---|---|---|
| 2019-06-30 | $133.00K 10-Q · filed 2019-08-12 | $266.00K 10-Q · filed 2019-08-12 |
| 2019-03-31 | $133.00K 10-Q · filed 2019-05-10 | |
| 2018-06-30 | $119.00K 10-Q · filed 2019-08-12 | $228.00K 10-Q · filed 2019-08-12 |
| 2018-03-31 | $109.00K 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |